Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Biomarin Technologies B V has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 distinct examiners and 2 distinct art units, indicating that the workload is spread across separate examination channels.
DACE DENITO, ALEXANDRA GERALDINE is the busiest examiner, with 1 pending office action. Counsel should coordinate the portfolio’s biotechnology and pharmaceutical positions while developing responses tailored to each assigned examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DACE DENITO, ALEXANDRA GERALDINE | 1 | 53.6% | +35.5% |
| ARIETI, RUTH SOPHIA | 1 | 45.7% | +71.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18179064 | OLIGOMERS HAVING BICYCLIC SCAFFOLD MOIETIES | DACE DENITO, ALEXANDRA GERALDINE | — |
| 17449290 | OLIGONUCLEOTIDE | ARIETI, RUTH SOPHIA | — |
| Art Unit | Apps |
|---|---|
| 1636 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18179064 | OLIGOMERS HAVING BICYCLIC SCAFFOLD MOIETIES | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §103Other | Final Rejection | — | Pending | Mar 06, 2023 |
| 17449290 | OLIGONUCLEOTIDE | ARIETI, RUTH SOPHIA | 1635 | §103Other | Non-Final OA | — | Pending | Sep 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBiomarin Technologies B V has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Alexandra Geraldine Dace Denito has the most, with 1 of Biomarin Technologies B V's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.